Instrument Inactif

Communiqués Serendex Pharmaceuticals A/S

Actions

SENDEX

DK0060563427

Recherche biotechnologique et médicale

Communiqués

12/07/16	Serendex Pharmaceuticals A/S : Minutes of Serendex’s Extraordinary General Meeting 2016	PU
21/06/16	Serendex Pharmaceuticals A/S : Savara Pharmaceuticals acquires Serendex	PU
25/05/16	Serendex Pharmaceuticals A/S : First patient dosed in Serendex’s pivotal trial for PAP	PU
12/05/16	Serendex Pharmaceuticals A/S : signs license agreement with Japanese partner	PU
02/05/16	Serendex Pharmaceuticals A/S : Delisting of Serendex as of 4 May 2016	PU
29/04/16	Serendex Pharmaceuticals A/S : Minutes of Serendex’s Ordinary General Meeting 2016	PU
28/04/16	Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Ordinary General Meeting	PU
04/04/16	Serendex Pharmaceuticals A/S : releases Annual Report 2015	PU
08/03/16	Serendex Pharmaceuticals A/S : secures credit facility	PU
07/03/16	Serendex Pharmaceuticals A/S : to delist from Oslo Axess; to terminate market making agreement with NORNE A/S	PU
19/02/16	Serendex Pharmaceuticals A/S : pivotal clinical trial for PAP approved in Japan	PU
19/02/16	Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016	PU
10/02/16	Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016	PU
10/02/16	Serendex Pharmaceuticals A/S : Minutes from Serendex’s Extraordinary General Meeting	PU
09/02/16	Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Extraordinary General Meeting	PU
28/01/16	Serendex Pharmaceuticals A/S : establishes a warrant programme for the company’s employees	PU
25/01/16	Serendex Pharmaceuticals A/S : Extraordinary General Meeting – correction to “The Complete Proposals”	PU
13/01/16	Serendex Pharmaceuticals A/S : New share capital registered – correction of previously announced result of the issue	PU
06/01/16	Serendex Pharmaceuticals A/S : Primary insider notification	PU
06/01/16	Serendex Pharmaceuticals A/S : The Rights Issue in Serendex Pharmaceuticals A/S was fully subscribed	PU
06/01/16	Serendex Pharmaceuticals A/S : Major shareholding notification	PU
18/12/15	Serendex Pharmaceuticals A/S : to potentially enter into license agreement with strategic partner for Japan	PU
10/12/15	Serendex Pharmaceuticals A/S : Rights issue – record date information	PU
10/12/15	Serendex Pharmaceuticals A/S : Strategic review and future financing	PU
03/12/15	Serendex Pharmaceuticals A/S : Primary insider notification	PU